Glenmede Trust Co. NA grew its stake in shares of CME Group Inc (NASDAQ:CME) by 156.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 167,321 shares of the financial services provider’s stock after acquiring an additional 102,052 shares during the quarter. Glenmede Trust Co. NA’s holdings in CME Group were worth $27,427,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of CME. Oak Ridge Investments LLC boosted its holdings in CME Group by 6.2% in the 2nd quarter. Oak Ridge Investments LLC now owns 5,247 shares of the financial services provider’s stock worth $860,000 after acquiring an additional 306 shares during the period. Girard Partners LTD. boosted its stake in shares of CME Group by 10.3% during the 2nd quarter. Girard Partners LTD. now owns 3,492 shares of the financial services provider’s stock valued at $572,000 after buying an additional 326 shares during the last quarter. Trust Co. of Vermont boosted its stake in shares of CME Group by 0.8% during the 2nd quarter. Trust Co. of Vermont now owns 43,772 shares of the financial services provider’s stock valued at $7,175,000 after buying an additional 327 shares during the last quarter. Front Row Advisors LLC boosted its stake in shares of CME Group by 3.9% during the 2nd quarter. Front Row Advisors LLC now owns 8,882 shares of the financial services provider’s stock valued at $1,506,000 after buying an additional 335 shares during the last quarter. Finally, MayTech Global Investments LLC boosted its stake in shares of CME Group by 0.7% during the 2nd quarter. MayTech Global Investments LLC now owns 50,090 shares of the financial services provider’s stock valued at $8,211,000 after buying an additional 338 shares during the last quarter. 84.03% of the stock is owned by institutional investors.

Shares of NASDAQ:CME traded up $0.47 on Friday, hitting $176.50. The company’s stock had a trading volume of 1,734,102 shares, compared to its average volume of 1,566,127. CME Group Inc has a 12 month low of $132.33 and a 12 month high of $182.97. The stock has a market cap of $57.79 billion, a price-to-earnings ratio of 37.00, a PEG ratio of 3.20 and a beta of 0.64. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.08 and a current ratio of 1.08.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, July 26th. The financial services provider reported $1.74 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.72 by $0.02. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The company had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the prior year, the business posted $1.22 earnings per share. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. On average, equities research analysts predict that CME Group Inc will post 6.64 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 25th. Investors of record on Monday, September 10th were paid a dividend of $0.70 per share. The ex-dividend date was Friday, September 7th. This represents a $2.80 annualized dividend and a yield of 1.59%. CME Group’s dividend payout ratio is currently 58.70%.

In related news, CAO Jack J. Tobin sold 7,820 shares of the firm’s stock in a transaction dated Wednesday, September 5th. The stock was sold at an average price of $174.87, for a total transaction of $1,367,483.40. Following the completion of the transaction, the chief accounting officer now owns 17,534 shares of the company’s stock, valued at $3,066,170.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, President Bryan T. Durkin sold 11,509 shares of the stock in a transaction on Monday, August 6th. The shares were sold at an average price of $162.01, for a total value of $1,864,573.09. Following the completion of the transaction, the president now owns 64,862 shares of the company’s stock, valued at approximately $10,508,292.62. The disclosure for this sale can be found here. Insiders have sold 26,688 shares of company stock valued at $4,523,957 in the last ninety days. Company insiders own 0.43% of the company’s stock.

Several equities analysts have recently commented on the company. Berenberg Bank set a $184.00 target price on CME Group and gave the company a “hold” rating in a research note on Thursday, September 20th. Wells Fargo & Co upped their price target on CME Group from $170.00 to $175.00 and gave the company a “market perform” rating in a research report on Monday, July 9th. BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Compass Point assumed coverage on CME Group in a research report on Monday, July 9th. They set a “neutral” rating and a $170.00 price target on the stock. Finally, Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Five equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $178.93.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: How can investors find ex-dividend dates?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.